Showing results (1931-1940 of 1,998) with videos related to

Sort By:
Pageof 200
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2021
Global Respiratory Syncytial Virus-Related Infant Community DeathsNatalie I Mazur, Yvette N Löwensteyn, Joukje E Willemsen, et al.
Plos One|November 20, 2013
Somatic point mutation calling in low cellularity tumorsKarin S Kassahn, Oliver Holmes, Katia Nones, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Gut|October 30, 2017
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancerAngela Chou, Danielle Froio, Adnan M Nagrial, et al.
Cancer Immunology Research|March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalNicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Cancer Research|December 3, 2015
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasStephen Q Wong, Kelly Waldeck, Ismael A Vergara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2020
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapyBoris V Janssen, Faik Tutucu, Stijn van Roessel, et al.
Nature Communications|March 18, 2025
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
JAMA|June 21, 2021
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 StatementAaron M Orkin, Peter J Gill, Davina Ghersi, et al.
Nature Communications|August 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecanClaire Vennin, Pauline Mélénec, Romain Rouet, et al.
Pageof 200